#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leber's congenital amaurosis Cholestatic pruritus Small cell lung cancer recurrent Alveolar proteinosis Ichthyosis Acute respiratory distress syndrome Testicular leiomyosarcoma B-cell small lymphocytic lymphoma Eosinophilic oesophagitis Pericarditis Idiopathic intracranial hypertension Neurodegenerative disorder T-cell lymphoma Asthma Chondrosarcoma metastatic More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Treatment Hereditary motor and sensory neuropathy Chondrosarcoma metastatic – Diagnostics Synovial sarcoma – Basic Information Piriformis syndrome – Life with Disease Cytokine release syndrome – Diagnostics Noonan syndrome – Treatment Wiskott-Aldrich syndrome – Diagnostics Prolymphocytic leukaemia – Treatment Alport’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Epinephrine Bitartrate VENT-03 Pentixather Barzolvolimab PIROXICAM Tralokinumab Evolocumab Tasipimidine Crizanlizumab Phleum Pratense Opevesostat Cl-Ad-Msc-002 Festuca Elatior Pollen Extract Afimetoran Besilate Dihydrate Surzebiclimab Tozinameran Isoleucine Rondaptivon Pegol Antiemetics And Antinauseants PARECOXIB More therapies…

    Learn about Your Condition

    Androgenetic alopecia Venous thrombosis Abdominal infection Multifocal motor neuropathy Asplenia Rheumatoid arthritis Vulvovaginal dryness Arthritis infective Genital infection female Conjunctivitis Bladder cancer Congenital myopathy Impaired gastric emptying Fibromyalgia BK virus infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Atrial fibrillation

  • Study on the Safety and Effectiveness of Warfarin for Patients with Atrial Fibrillation Undergoing Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemodialysis
    • Peritoneal dialysis
    • Atrial fibrillation
    Investigated Drugs:
    • Warfarin Sodium
    Denmark

  • Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

    Recruiting

    3 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Abelacimab
    Bulgaria Croatia Czechia Estonia Finland Germany +9

  • Study on Stopping Anticoagulants in Atrial Fibrillation Patients After Surgery: Warfarin, Rivaroxaban, Apixaban, Edoxaban, Dabigatran, and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Apixaban
    • Dabigatran
    • Edoxaban
    Denmark Sweden

  • Phase 3 Study of Etripamil Nasal Spray Compared with Placebo in Patients with Atrial Fibrillation and Rapid Ventricular Rate

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Etripamil
    The Netherlands

  • Safety and Pharmacodynamics of RBD4059 and Apixaban in Patients with Non‑Valvular Atrial Fibrillation: A Randomized Active‑Controlled Study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Rbd4059
    • Apixaban
    Denmark Norway Poland Sweden

  • Safety of flecainide acetate compared with amiodarone hydrochloride and sotalol in patients with atrial fibrillation and stable coronary artery disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    • Coronary artery disease
    Investigated Drugs:
    • Flecainide Acetate
    • Sotalol
    • Amiodarone Hydrochloride
    Belgium
Previous Page
1 … 3 4 5 6 7 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!